Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's DiseaseGlobeNewsWire • 05/15/23
Eli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also RisesInvestors Business Daily • 05/03/23
Alzheimer's patients may wait years to get treated with new drugs, putting them at risk of more severe diseaseCNBC • 04/30/23
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALSGlobeNewsWire • 04/25/23
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer's drug space, CEO saysCNBC • 04/25/23
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the diseaseCNBC • 04/25/23
Biogen Inc. (BIIB) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/25/23
Alzheimer's Drugs Still Aren't Biogen's Saving Grace — But The Company Is HopefulInvestors Business Daily • 04/25/23
Alzheimer's patients retain the benefits of Leqembi even when they stop the drug, Eisai saysCNBC • 04/06/23
Ionis And Biogen: Tofersen PDUFA Looms - Positive Outcome May Kick Off Bull Run For Both StocksSeeking Alpha • 04/06/23